Loading clinical trials...
Loading clinical trials...
Thermal Ablation Combined With Low-dose Donafinib for Early Recurrent Hepatocellular Carcinoma: a Multicenter Prospective Study
Conditions
Interventions
Thermal ablation
Donafenib
Locations
1
China
Chinese PLA General hospital
Beijing, None Selected, China
Start Date
October 1, 2024
Primary Completion Date
October 1, 2026
Completion Date
October 1, 2028
Last Updated
December 3, 2024
NCT07175441
NCT05969860
NCT06427941
NCT05842174
NCT07164313
NCT07118202
Lead Sponsor
Sun Yat-sen University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions